How to Buy Anika Therapeutics Stock
Anika Therapeutics Inc
Anika Therapeutics, Inc. , a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally.
Anika Therapeutics stock last closed at $26.49, up 2.32% from the previous day, and has increased 1.88% in one year. It has overperformed other stocks in the Medical Devices industry by 0.17 percentage points. Anika Therapeutics stock is currently +60.16% from its 52-week low of $16.54, and -5.81% from its 52-week high of $28.13.
As of May 1, 2024, there are 14.85M ANIK shares outstanding. The market cap of ANIK is $393.37M. In the past 24 hours, 71,391 ANIK shares were traded.
How to Buy Anika Therapeutics Stock
Wondering how to invest in Anika Therapeutics stock? Here's how.
- Choose where to buy Anika Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you determine where to buy Anika Therapeutics stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your investment account: Pick your payment method and add your info.
- Analyze Anika Therapeutics stock: The Anika Therapeutics ticker symbol is ANIK. Is Anika Therapeutics stock a good investment? Should you buy shares of ANIK? How do ANIK's underlying business fundamentals look? Do top analysts think Anika Therapeutics is a good buy? Why has ANIK's stock price moved recently? (Hint: Our stock market research website can help you evaluate if ANIK is a good stock to buy).
- Execute your ANIK buy order: Decide if you will purchase ANIK shares at the current market price or use a limit order to buy ANIK stock at a specific price.
- Get key alerts regarding your investment in ANIK: Create a watchlist to monitor your position in Anika Therapeutics shares.
Step 1: Choose where to buy Anika Therapeutics stock
You will need an online brokerage account to access the NASDAQ market and buy ANIK shares.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Tech to Healthcare, New York to Shanghai — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by creating an account with eToro now.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen your brokerage, the next step is to fill out some personal details so you can buy ANIK today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to open your new trading account.
- Send your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have opened your account on one of the most highly reviewed stock market apps, you can securely and quickly fund your account:
Watch this video walkthrough if you need help transferring funds into your investment account.
Step 4: Analyze Anika Therapeutics stock
Once you have figured out the best place to buy Anika Therapeutics stock, it's critical to research their stock before you invest, so you can comprehend the risk as well as the upside.
Anika Therapeutics quick stats
Fundamentals of ANIK
WallStreetZen was built to help everyday investors perform better fundamental analysis in less time.
You can see all of the due diligence checks on ANIK's stock page.
Is ANIK stock overvalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge ANIK's intrinsic value.
Using relative valuations metrics:
- ANIK may be undervalued based on its P/B ratio of 1.85x, relative to Medical Devices industry P/B ratio of 3.68x
You can access additional valuation research on ANIK's stock here.
A look at ANIK Cashflows and Balance Sheet
Positive Financial Indicators:
- ANIK has a low debt to equity ratio of 0.28.
- ANIK has cash burn of 7215000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the ANIK balance sheet.
- There are more short-term assets than short-term liabilities on the ANIK balance sheet.
- ANIK has $72.87M in cash and short term investments. This is enough to cover its annual cash burn of $7.22M.
Negative Financial Indicators:
- Total ANIK debt is higher than 5 years ago, relative to shareholder equity.
- ANIK profit margin has gone down from -9.5% to -49.6% in the past year.
Do Wall Street analysts think it's a good time to buy Anika Therapeutics stock
Out of 2 sell side analysts who monitor ANIK, the consensus analyst rating on Anika Therapeutics is a Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are forecasting on the Anika Therapeutics stock forecast page.
Metrics for Advanced ANIK Traders
ANIK Earnings
Last year, ANIK revenue was $166.66M. In the past five year, ANIK's revenue has increased by 9.56% per year. This was slower than the Medical Devices industry average of 13.03%.
You can research ANIK's earnings and revenue performance here.
What are ANIK insiders up to?
In the last 12 months, insiders at ANIK have sold more shares than they have bought.
Cheryl R. Blanchard, President CEO Director of ANIK, was the latest ANIK insider to sell. They sold $374,831.86 worth of ANIK stock on Mar 11, 2024.
Learn more about who owns ANIK shares here.
Does ANIK stock generate passive income?
No, Anika Therapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about ANIK?
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Execute your ANIK buy order
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally the best for newer investors. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a specific dollar amount limit, place a limit order.
Hit the Open button and eToro will execute the order.
If you want additional help with investing in stocks on eToro, click the how to video below:
Step 6: Get key alerts regarding your investment in ANIK
Now that you own some shares in ANIK, you'll want to keep up with your new stock purchase.
Create a watchlist to keep track of your ANIK stock.
ANIK Feed
How to Buy Stock in Anika Therapeutics
To reiterate, here are the 6 steps to buy Anika Therapeutics stock:
- Choose where to buy Anika Therapeutics stock
- Sign up for a brokerage account
- Deposit money your investment account
- Analyze Anika Therapeutics stock
- Execute your ANIK buy order
- Get key alerts regarding your investment in ANIK
If you are looking for a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Anika Therapeutics, add ANIK to your watchlist below.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.